Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acecainide Hydrochloride
2. Acecainide Monohydrochloride
3. Acetylprocainamide
4. Hydrochloride, Acecainide
5. Monohydrochloride, Acecainide
6. N Acetylprocainamide
7. N-acetylprocainamide
1. N-acetylprocainamide
2. 32795-44-1
3. Napa
4. Acekainid
5. Acecainida
6. Acecainidum
7. N-acetyloprokainamid
8. Acetylprocainamide
9. Acecainide [inn]
10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide
11. N-acetylprocaine Amide
12. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide
13. Acecainide;napa
14. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-
15. N-acetylnovocainamide
16. N-acetyl-procainamide
17. Chebi:60728
18. Acetylprocainamide, N-
19. N-[2-(diethylamino)ethyl]-4-acetamidobenzamide
20. Chembl1097
21. Mls000069490
22. 910q707v6f
23. Acetanilide, 4'-((2-(diethylamino)ethyl)carbamoyl)-
24. Smr000059070
25. Acekainid [polish]
26. Acecainidum [inn-latin]
27. Acecainida [inn-spanish]
28. N-acetyloprokainamid [polish]
29. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide
30. Brn 2868559
31. Unii-910q707v6f
32. Procainamide-n-acetyl
33. N-acetyl Procainamide
34. Acecainide [mi]
35. Opera_id_1541
36. Spectrum3_001843
37. Lopac-a-5909
38. Epitope Id:140121
39. Acecainide [who-dd]
40. Lopac0_000009
41. Bspbio_003226
42. Mls001146871
43. Schembl156943
44. N-acetylprocainamide, >=99%
45. Dtxsid6048414
46. Kbio3_002726
47. Hms2232g18
48. Hms3372e09
49. Bcp26213
50. Hy-b1109
51. Zinc1999404
52. Bdbm50151860
53. Akos016614968
54. N-acetyl Procainamide(<30%)
55. Ccg-204105
56. Cs-4707
57. Sdccgsbi-0049998.p003
58. Ncgc00015072-01
59. Ncgc00015072-02
60. Ncgc00015072-03
61. Ncgc00015072-04
62. Ncgc00015072-05
63. Ncgc00015072-06
64. Ncgc00015072-07
65. Ncgc00015072-13
66. Ncgc00023226-03
67. Ncgc00023226-04
68. As-57414
69. Sbi-0049998.p002
70. Db-048268
71. N-acetylprocainamide 1.0 Mg/ml In Methanol
72. Ft-0639052
73. Ab00384286_20
74. 4-acetylamino-n-(2-diethylamino-ethyl)-benzamide
75. A905428
76. J-018880
77. Q4726688
78. 4-(acetylamino)-n-[2-(diethylamino)ethyl]benzamide #
79. Brd-k07753030-003-01-0
80. Brd-k07753030-003-11-9
81. Z26393212
82. N-(4-{[2-(diethylamino)ethyl]carbamoyl}phenyl)ethanimidic Acid
Molecular Weight | 277.36 g/mol |
---|---|
Molecular Formula | C15H23N3O2 |
XLogP3 | 0.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 7 |
Exact Mass | 277.17902698 g/mol |
Monoisotopic Mass | 277.17902698 g/mol |
Topological Polar Surface Area | 61.4 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 308 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Acecainide is a known human metabolite of Procainamide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ANALYTICAL
ABOUT THIS PAGE
A Acecainida manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acecainida, including repackagers and relabelers. The FDA regulates Acecainida manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acecainida API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acecainida supplier is an individual or a company that provides Acecainida active pharmaceutical ingredient (API) or Acecainida finished formulations upon request. The Acecainida suppliers may include Acecainida API manufacturers, exporters, distributors and traders.
Acecainida Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acecainida GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acecainida GMP manufacturer or Acecainida GMP API supplier for your needs.
A Acecainida CoA (Certificate of Analysis) is a formal document that attests to Acecainida's compliance with Acecainida specifications and serves as a tool for batch-level quality control.
Acecainida CoA mostly includes findings from lab analyses of a specific batch. For each Acecainida CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acecainida may be tested according to a variety of international standards, such as European Pharmacopoeia (Acecainida EP), Acecainida JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acecainida USP).
LOOKING FOR A SUPPLIER?